Rescission Watch: Take action to protect cancer research funding!
Last week, we joined with other research advocates to thank Congressional appropriations leaders for securing an unprecedented $3 billion increase in NIH funding as part of the FY2018 omnibus spending bill. This boost to medical research funding comes at a critical time, as advances in precision medicine hold the key to more children surviving and thriving after a cancer diagnosis than ever before.
But then, we started hearing a term called “rescission” thrown around in Washington. An appropriations process that we had celebrated as a victory for medical research suddenly started to sound not-so-final.
Here’s the issue: President Trump signed the $1.3 trillion FY2018 omnibus into law – but has reportedly been considering a rescission package. Rescission is a process by which the president formally requests (within 45 days of a spending bill’s passage) that Congress backtrack and cut out some of what has already been signed into law.
This gets complicated and wonky but here’s the gist of it: A large and united community of public health and medical advocates spoke up to ensure strong funding for the National Institutes of Health – and now we must speak up once again to protect that funding. We’re asking advocates to call, email or tweet their Senators and Representative today and urge them to defend the budget and rebuff any attempt at rescission that would put life-saving research funding at risk. We have an action alert below that makes it quick and easy!
We don’t want to be alarmist. In fact, several Senate Republicans have spoken out against rescission and we’re grateful for their strong leadership. But House Majority Leader Kevin McCarthy and now Senate Majority Leader Mitch McConnell are open to the prospect.
We just want to make sure Congress knows our community is paying close attention. We know this investment in the NIH will help spur medical research and innovation that will save lives in many disease areas, including pediatric cancers.